FinThrive™ Announces New Autonomous Revenue Management Research and Speaking Sessions at HFMA Annual Conference 2022 – QNT Press Release

[ad_1]

Research points to the key reasons CFOs are shifting away from RCM point solutions toward holistic revenue management technologies.

DENVER, June 26, 2022 /PRNewswire/ — FinThrive, Inc., backed by Clearlake Capital Group, LP (together with certain affiliates, “Clearlake”), a healthcare revenue management software-as-a-service (SaaS) provider with the industry’s most comprehensive end- to-end platform, will release new research from its autonomous revenue management playbook and participate in three speaking sessions at the HFMA Annual Conference June 26-29.

The current state of healthcare has proved to be a costly problem for providers, payers and patients. Bolt-on solutions, from multiple vendors, have only exacerbated financial downfall, leading to recurring denials, underpayments, and high vendor management costs. Recent research sponsored by FinThrive reported that 29% of health system CFOs plan to invest in a single-vendor revenue management platform solution within the next 12 months; another 36% intend to go to market within the next two years. The rise of revenue management platforms represents the most significant technology shift since industry wide EHR (Electronic Health Record) adoption in 2015.

“Uncompensated care climbed to $42.7 billion in 2020. This means the current system is not working as well as it should,” said Hemant GoelPresident …

Full story available on Benzinga.com

[ad_2]

Source link